Dr. Fytianos completed his PhD in Biology at the University of Fribourg in Switzerland. During his PhD, he investigated nanoparticle interactions with human immune cells and advanced in vitro models for respiratory diseases. Afterwards, he pursued postdoctoral research in biomedicine and translational medicine, with a focus on respiratory disease models (in vitro and in vivo). Since 2019, he has worked for CSL Behring R&D department as a Senior Scientist. He currently leads several projects in the respiratory therapeutic area that are at a preclinical stage. His team focuses on relevant and physiological in vitro and ex vivo experimental disease models that could support later stages of development.

In this webinar, Dr. Fytianos will:

  • Discuss the characterization of heme-induced injury on PCLS
  • Explain methods optimization in producing high-quality PCLS
  • Discuss clinical and research translatability of PCLS